QOF database

Home | News | Downloads
DR. CHAMBERS & PARTNERS

DR. CHAMBERS & PARTNERS

BALLYSILLAN GROUP PRACTICE, BALLYSILLAN GROUP PRACTICE, 156-158 BALLYSILLAN ROAD, BELFAST

Stroke 12

The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)

IndicatorYearNumeratorDenominatorRatioCentile
STROKE 9 2005 29 32 90.6%
STROKE 9 2006 28 31 90.3%
Stroke 12 2007 19 20 95.0%
Stroke 12 2008 20 22 90.9%
Stroke 12 2009 23 24 95.8%
Stroke 12 2010 28 29 96.6%
STROKE 12 2011 35 35 100.0%
STROKE 12 2012 43 43 100.0%
STROKE 12 2013 43 44 97.7%
STIA007NI 2014 44 47 93.6%
STIA007 2015 50 55 90.9%
STIA007 2016 91 93 97.8%
STIA007 2017 84 89 94.4%
STIA007 2018 84 89 94.4%
STIA007 2019 83 88 94.3%
STIA007 2020 85 91 93.4%
STIA007 2021 84 93 90.3%